Gender differences of peripheral plasma and liver metabolic profiling in APP/PS1 transgenic AD mice

Neuroscience

Volumn 332, Issue , 2016, Pages 160-169

  Wu, Junfang ^a   Fu, Bin ^b   Lei, Hehua ^a   Tang, Huiru ^a,c   Wang, Yulan ^a,d  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b Hubei Provincial Hospital of Integrated Chinese and Western Medicine   (China)

^c FUDAN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; fatty acids; gender difference; liver extracts; metabonomics; peripheral

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACYL COENZYME A DESATURASE; AMYLOID PRECURSOR PROTEIN; FATTY ACID; GLUCOSE; LIPID; MONOUNSATURATED FATTY ACID; NUCLEOTIDE; PRESENILIN 1; APP PROTEIN, HUMAN; BIOLOGICAL MARKER; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATABOLISM; CELL ENERGY; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID DESATURATION; FEMALE; LIVER; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLITE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; SEX DIFFERENCE; AMYLOID PLAQUE; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; METABOLOME; MULTIVARIATE ANALYSIS; PATHOLOGY; PHYSIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; SEXUAL CHARACTERISTICS; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BIOMARKERS; DISEASE MODELS, ANIMAL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIVER; MALE; METABOLOME; MICE, TRANSGENIC; MULTIVARIATE ANALYSIS; PLAQUE, AMYLOID; PRESENILIN-1; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SEX CHARACTERISTICS;

EID: 84978380216     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.06.049     Document Type: Article

References (66)

1. An, Y., Xu, W., Li, H., Lei, H., Zhang, L., Hao, F., Duan, Y., Yan, X., Zhao, Y., Wu, J., Wang, Y., Tang, H., High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats. J Proteome Res 12 (2013), 3755–3768.
2. Anstey, K.J., Lipnicki, D.M., Low, L.-F., Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16 (2008), 343–354.
3. Astarita, G., Jung, K.-M., Berchtold, N.C., Nguyen, V.Q., Gillen, D.L., Head, E., Cotman, C.W., Piomelli, D., Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS One, 5, 2010, e12538.
4. Avdulov, N.A., Chochina, S.V., Igbavboa, U., Warden, C.S., Vassiliev, A.V., Wood, W.G., Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J Neurochem 69 (1997), 1746–1752.
5. Barba, I., Fernandez-Montesinos, R., Garcia-Dorado, D., Pozo, D., Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. J Cell Mol Med 12 (2008), 1477–1485.
6. Blass, J.P., Brain metabolism and brain disease: is metabolic deficiency the proximate cause of alzheimer dementia?. J Neurosci Res 66 (2001), 851–856.
7. Braak, H., Braak, E., Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1 (1991), 213–216.
8. Butterfield, D.A., Drake, J., Pocernich, C., Castegna, A., Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid B-peptide. Trends Mol Med 7 (2001), 548–554.
9. Clayton, T.A., Lindon, J.C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R.J., Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440 (2006), 1073–1077.
10. Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., Troncoso, J.C., Mattson, M.P., Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 101 (2004), 2070–2075.
11. Dobrzyn, A., Ntambi, J.M., The role of stearoyl-COA desaturase in the control of metabolism. Prostaglandins Leukot Essent Fatty Acids 73 (2005), 35–41.
12. Ehehalt, R., Keller, P., Haass, C., Thiele, C., Simons, K., Amyloidogenic processing of the Alzheimer B-amyloid precursor protein depends on lipid rafts. J Cell Biol 160 (2003), 113–123.
13. Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2006), 2112–2117.
14. Francis, Y.I., Fà, M., Ashraf, H., Zhang, H., Staniszewski, A., Latchman, D.S., Arancio, O., Dysregulation of histone acetylation in the App/Ps1 mouse model of Alzheimer's disease. J Alzheimer's Dis 18 (2009), 131–139.
15. Ganguli, M., Dodge, H., Chen, P., Belle, S., DeKosky, S., Ten-year incidence of dementia in a rural elderly us community population the movies project. Neurology 54 (2000), 1109–1116.
16. Gibson, G., Haroutunian, V., Zhang, H., Park, L., Shi, Q., Lesser, M., Mohs, R., Sheu, R., Blass, J., Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 48 (2000), 297–303.
17. Gillies, G.E., Pienaar, I.S., Vohra, S., Qamhawi, Z., Sex differences in Parkinson's disease. Front Neuroendocrinol 35 (2014), 370–384.
18. Gonzalez-Dominguez, R., Garcia-Barrera, T., Vitorica, J., Gomez-Ariza, J.L., Metabolomics reveals significant impairments in the immune system of the App/Ps1 transgenic mice of Alzheimer's disease. Electrophoresis 36 (2015), 577–587.
19. Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
20. Jiang, N., Yan, X., Zhou, W., Zhang, Q., Chen, H., Zhang, Y., Zhang, X., NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse. J Proteome Res 7 (2008), 3678–3686.
21. Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D.D., Metter, E., A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 48 (1997), 1517–1521.
22. Kelly, P., McClean, P.L., Ackermann, M., Konerding, M.A., Hölscher, C., Mitchell, C.A., Restoration of cerebral and systemic microvascular architecture in App/Ps1 transgenic mice following treatment with Liraglutide™. Microcirculation 22 (2015), 133–145.
23. Kivipelto, M., Solomon, A., Cholesterol as a risk factor for Alzheimer's disease—epidemiological evidence. Acta Neurol Scand 114 (2006), 50–57.
24. Lan, M., McLoughlin, G., Griffin, J., Tsang, T., Huang, J., Yuan, P., Manji, H., Holmes, E., Bahn, S., Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 14 (2009), 269–279.
25. Lattka, E., Illig, T., Koletzko, B., Heinrich, J., Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 21 (2010), 64–69.
26. Li, N.-J., Liu, W.-t., Li, W., Li, S.-q., Chen, X.-h., Bi, K.-s., He, P., Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry. Clin Biochem 43 (2010), 992–997.
27. Li, N., Zhang, L., An, Y., Zhang, L., Song, Y., Wang, Y., Tang, H., Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice. J Proteome Res 14 (2015), 1566–1573.
28. Li, R., Singh, M., Sex differences in cognitive impairment and Alzheimer's disease. Front Neuroendocrinol 35 (2014), 385–403.
29. Lindon, J.C., Nicholson, J.K., Holmes, E., The handbook of metabonomics and metabolomics. 2011, Elsevier.
30. Liu, Y., Jandacek, R., Rider, T., Tso, P., McNamara, R.K., Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: relationship with fatty acid composition. Schizophr Res 109 (2009), 113–120.
31. Liu, Y., McNamara, R.K., Elevated delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder. J Psychiatr Res 45 (2011), 269–272.
32. Mattson, M.P., Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77 (1997), 1081–1132.
33. Mishra, O.P., Delivoria-Papadopoulos, M., Cahillane, G., Wagerle, L.C., Lipid peroxidation as the mechanism of modification of brain 5′-nucleotidase activity in vitro. Neurochem Res 15 (1990), 237–242.
34. Mochel, F., Charles, P., Seguin, F., Barritault, J., Coussieu, C., Perin, L., Le Bouc, Y., Gervais, C., Carcelain, G., Vassault, A., Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One, 2, 2007, e647.
35. Montine, T.J., Quinn, J.F., Montine, K.S., Kaye, J.A., Breitner, J., Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. J Alzheimer's Dis 8 (2005), 359–367.
36. Mosconi, L., Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32 (2005), 486–510.
37. Mufson, E.J., Leurgans, S., Inability of plasma and urine F2a-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease. Neurodegen Dis 7 (2010), 139–142.
38. Murphy, D.G., DeCarli, C., McIntosh, A.R., Daly, E., Mentis, M.J., Pietrini, P., Szczepanik, J., Schapiro, M.B., Grady, C.L., Horwitz, B., Rapoport, S.I., sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 53 (1996), 585–594.
39. Nasaruddin, M.L., Hölscher, C., Kehoe, P., Graham, S.F., Green, B.D., Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MS. Am J Transl Res, 8, 2016, 154.
40. Nicholson, J.K., Foxall, P.J., Spraul, M., Farrant, R.D., Lindon, J.C., 750 MHz 1H and 1H–13C NMR spectroscopy of human blood plasma. Anal Chem 67 (1995), 793–811.
41. Ntambi, J.M., Miyazaki, M., Stoehr, J.P., Lan, H., Kendziorski, C.M., Yandell, B.S., Song, Y., Cohen, P., Friedman, J.M., Attie, A.D., Loss of stearoyl-COA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99 (2002), 11482–11486.
42. Pan, X., Nasaruddin, M.B., Elliott, C.T., McGuinness, B., Passmore, A.P., Kehoe, P.G., Hölscher, C., McClean, P.L., Graham, S.F., Green, B.D., Alzheimer's disease-like pathology has transient effects on the brain and blood metabolome. Neurobiol Aging 38 (2016), 151–163.
43. Park, H., Hasegawa, G., Shima, T., Fukui, M., Nakamura, N., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels. Clin Chim Acta 411 (2010), 1735–1740.
44. Paulson, P.E., Minoshima, S., Morrow, T.J., Casey, K.L., Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans. Pain 76 (1998), 223–229.
45. Pedrono, F., Blanchard, H., Kloareg, M., D'Andrea, S., Daval, S., Rioux, V., Legrand, P., The fatty acid desaturase 3 gene encodes for different FADS3 protein isoforms in mammalian tissues. J Lipid Res 51 (2010), 472–479.
46. Puglielli, L., Tanzi, R.E., Kovacs, D.M., Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6 (2003), 345–351.
47. Querfurth, H.W., LaFerla, F.M., Mechanisms of disease. N Engl J Med 362 (2010), 329–344.
48. Ruitenberg, A., Ott, A., van Swieten, J.C., Hofman, A., Breteler, M.M., Incidence of dementia: does gender make a difference?. Neurobiol. Aging 22 (2001), 575–580.
49. Salek, R.M., Xia, J., Innes, A., Sweatman, B.C., Adalbert, R., Randle, S., McGowan, E., Emson, P.C., Griffin, J.L., A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem. Int. 56 (2010), 937–947.
50. Sassone, J., Colciago, C., Cislaghi, G., Silani, V., Ciammola, A., Huntington's disease: the current state of research with peripheral tissues. Exp Neurol 219 (2009), 385–397.
51. Simpson, I.A., Chundu, K.R., Davies-Hill, T., Honer, W.G., Davies, P., Decreased concentrations of Glut1 and Glut3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol 35 (1994), 546–551.
52. Slupsky, C.M., Rankin, K.N., Wagner, J., Fu, H., Chang, D., Weljie, A.M., Saude, E.J., Lix, B., Adamko, D.J., Shah, S., Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79 (2007), 6995–7004.
53. Steffen, L.M., Vessby, B., Jacobs, D., Steinberger, J., Moran, A., Hong, C.-P., Sinaiko, A.R., Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents. Int J Obes 32 (2008), 1297–1304.
54. Steingart, R.M., Packer, M., Hamm, P., Coglianese, M.E., Gersh, B., Geltman, E.M., Sollano, J., Katz, S., Moye, L., Basta, L.L., Sex differences in the management of coronary artery disease. N Engl J Med 325 (1991), 226–230.
55. Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., Mayeux, R., Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996), 429–432.
56. Tong, Z., Zhang, J., Luo, W., Wang, W., Li, F., Li, H., Luo, H., Lu, J., Zhou, J., Wan, Y., Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiol Aging 32 (2011), 31–41.
57. Trygg, J., Holmes, E., Lundstedt, T., Chemometrics in metabonomics. J Proteome Res 6 (2007), 469–479.
58. Trygg, J., Wold, S., Orthogonal projections to latent structures (O-PLS). J Chemom 16 (2002), 119–128.
59. Tukiainen, T., Tynkkynen, T., Mäkinen, V.-P., Jylänki, P., Kangas, A., Hokkanen, J., Vehtari, A., Gröhn, O., Hallikainen, M., Soininen, H., A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem Biophys Res Commun 375 (2008), 356–361.
60. Van den Berg, R.A., Hoefsloot, H.C., Westerhuis, J.A., Smilde, A.K., Van der Werf, M.J., Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genom, 7, 2006, 142.
61. Van Ginneken, C., Schäfer, K.-H., Van Dam, D., Huygelen, V., De Deyn, P.P., Morphological changes in the enteric nervous system of aging and App23 transgenic mice. Brain Res 1378 (2011), 43–53.
62. Warensjo, E., Ohrvall, M., Vessby, B., Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metabol Cardiovasc Dis 16 (2006), 128–136.
63. Whitacre, C.C., Sex differences in autoimmune disease. Nat Immunol 2 (2001), 777–780.
64. World Health Organization (2012) Dementia: a public health priority.
65. Wu, J., Xu, W., Ming, Z., Dong, H., Tang, H., Wang, Y., Metabolic changes reveal the development of schistosomiasis in mice. PLoS Negl Trop Dis, 4, 2010, e807.
66. Xu, Z., Harvey, K., Pavlina, T., Dutot, G., Zaloga, G., Siddiqui, R., An improved method for determining medium- and long-chain fames using gas chromatography. Lipids 45 (2010), 199–208.